Issue 2/2013
Content (21 Articles)
Neurocognitive deficits following primary brain tumor treatment: systematic review of a decade of comparative studies
Amanda K. Gehrke, Margaret C. Baisley, Alexander L. B. Sonck, Samantha L. Wronski, Michael Feuerstein
MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas
Omer Faruk Bayrak, Sukru Gulluoglu, Esra Aydemir, Ugur Ture, Hasan Acar, Basar Atalay, Zeynel Demir, Serhat Sevli, Chad J. Creighton, Michael Ittmann, Fikrettin Sahin, Mustafa Ozen
Trends in childhood brain tumor incidence, 1973–2009
Roberta McKean-Cowdin, Pedram Razavi, Jessica Barrington-Trimis, Rachel Tobias Baldwin, Shahab Asgharzadeh, Myles Cockburn, Tarik Tihan, Susan Preston-Martin
Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma
Melanie G. Hayden Gephart, YouRong Sophie Su, Samuel Bandara, Feng-Chiao Tsai, Jennifer Hong, Nicholas Conley, Helen Rayburn, Ljiljana Milenkovic, Tobias Meyer, Matthew P. Scott
The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells
Takuro Hayashi, Kazuhide Adachi, Shigeo Ohba, Yuichi Hirose
MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis
Yue-chao Fan, Peng-jin Mei, Chen Chen, Fa-an Miao, Hui Zhang, Zhong-lin Li
An in vivo mouse model of intraosseous spinal cancer causing evolving paraplegia
Davina A. F. Cossigny, Effie Mouhtouris, Sathana Dushyanthen, Augusto Gonzalvo, Gerald M. Y. Quan
MR-based hypoxia measures in human glioma
Vivien Tóth, Annette Förschler, Nuria M. Hirsch, Jürgen den Hollander, Hendrik Kooijman, Jens Gempt, Florian Ringel, Jürgen Schlegel, Claus Zimmer, Christine Preibisch
Relapse patterns in pediatric embryonal central nervous system tumors
Sébastien Perreault, Robert M. Lober, Anne-Sophie Carret, Guohua Zhang, Linda Hershon, Jean-Claude Décarie, Kristen Yeom, Hannes Vogel, Paul G. Fisher, Sonia Partap
Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery
Christopher P. Deibert, Manmeet S. Ahluwalia, Jason P. Sheehan, Michael J. Link, Toshinori Hasegawa, Shoji Yomo, Wu Han Feng, Pan Li, John C. Flickinger, L. Dade Lunsford, Douglas Kondziolka
Chronic epilepsy due to low grade temporal lobe tumors and due to hippocampal sclerosis: Do they differ in post-surgical outcome?
Prasad S. S. V. Vannemreddy, Andres M. Kanner, Michel C. Smith, Marvin Rossi, David Wallace, Siddharth N. K. Vannemreddy, Richard W. Byrne
5,10-Methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTRR), and methionine synthase reductase (MTR) gene polymorphisms and adult meningioma risk
Jun Zhang, Yan-Wen Zhou, Hua-Ping Shi, Yan-Zhong Wang, Gui-Ling Li, Hai-Tao Yu, Xin-You Xie
The role of adjuvant radiotherapy in atypical meningioma
Hae Jin Park, Hyun-Cheol Kang, Il Han Kim, Sung-Hye Park, Dong Gyu Kim, Chul-Kee Park, Sun Ha Paek, Hee-Won Jung
cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome
Yazmin Odia, Brent A. Orr, W. Robert Bell, Charles G. Eberhart, Fausto J. Rodriguez
Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy
F. Ducray, G. Kaloshi, C. Houillier, A. Idbaih, B. Ribba, D. Psimaras, Y. Marie, B. Boisselier, A. Alentorn, L. Dainese, S. Navarro, K. Mokhtari, M. Sanson, K. Hoang-Xuan, Jean-Yves Delattre
Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival
Christina Chen, Raymond Huang, Ainsley MacLean, Alona Muzikansky, Srinivasan Mukundan, Patrick Y. Wen, Andrew D. Norden
Institutional charges and disparities in outpatient brain biopsies in four US States: The State Ambulatory Database (SASD)
Kimon Bekelis, Symeon Missios, David W. Roberts
Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients
Chunxia Du, Ruoxi Hong, Yuankai Shi, Xiaoduo Yu, Jinwan Wang
Pregnancy in women with gliomas: a case-series and review of the literature
Hanneke Zwinkels, Joep Dörr, Fred Kloet, Martin J. B. Taphoorn, Charles J. Vecht
Glioblastoma management in the temozolomide era: have we improved outcome?
Zarnie Lwin, Derek MacFadden, Ahmed Al-Zahrani, Eshetu Atenafu, Barbara Ann Miller, Arjun Sahgal, Cynthia Menard, Normand Laperriere, Warren P. Mason
Industry progress report on neuro-oncology: Biotech update 2013
Malte Ottenhausen, Imithri Bodhinayake, Matei Banu, Kartik Kesavabhotla, Ashley Ray, John A. Boockvar